Fig. 2: Kaplan–Meier overall survival curves.

a Comparison of overall survival between KTs of gastric and colorectal origin. b Comparison of overall survival for synchronous cancers between KTs of gastric and colorectal origin. c Comparison of overall survival between HER2-positive and HER2-negative cases. d Comparison of overall survival between FGFR2-positive and FGFR2-negative cases.